The Trimodality Treatment Approach in Stage III/pN2 Non-Small Cell Lung Cancer: "Usually Appropriate" May Well be a Very Inappropriate Treatment Option.
*Institute of Lung Diseases, Sremska Kamenica, and BioIrc Centre for Biomedical Research, Kragujevac, Serbia †University Clinic, Barcelona, Spain ‡University Hospital to East Slovakia Institute of Oncology, Kosice, Slovakia §Inselspital, Bern, Switzerland ∥University Hospital, Santiago de Compostela Spain.
Branislav
B
Jeremic
Francesc
F
Casas
Pavol
P
Dubinsky
Nikola
N
Cihoric
Antonio
A
Gomez-Caamano
D002289:Carcinoma, Non-Small-Cell Lung / Q000628:therapy*; D017024:Chemotherapy, Adjuvant / Q000379:methods*; D006801:Humans; D008175:Lung Neoplasms / Q000628:therapy*; D011013:Pneumonectomy / Q000379:methods*; D018714:Radiotherapy, Adjuvant / Q000379:methods*